[1]韦春峥,莫 彬,莫善圆,等.孟鲁司特钠联合布地奈德治疗儿童支气管哮喘合并变应性鼻炎的临床效果[J].医学信息,2019,(20):142-144.[doi:10.3969/j.issn.1006-1959.2019.20.044]
 WEI Chun-zheng,MO Bin,MO Shan-yuan,et al.Clinical Effect of Montelukast Sodium Combined with Budesonide in the Treatment of Children with Bronchial Asthma Complicated with Allergic Rhinitis[J].Medical Information,2019,(20):142-144.[doi:10.3969/j.issn.1006-1959.2019.20.044]
点击复制

孟鲁司特钠联合布地奈德治疗儿童支气管哮喘合并变应性鼻炎的临床效果()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2019年20期
页码:
142-144
栏目:
药物与临床
出版日期:
2019-10-15

文章信息/Info

Title:
Clinical Effect of Montelukast Sodium Combined with Budesonide in the Treatment of Children with Bronchial Asthma Complicated with Allergic Rhinitis
文章编号:
1006-1959(2019)20-0142-03
作者:
韦春峥莫 彬莫善圆黄 涛
(河池市第三人民医院儿科,广西 河池 547000)
Author(s):
WEI Chun-zhengMO BinMO Shan-yuanHUANG Tao
(Department of Pediatrics,the Third People's Hospital of Hechi,Hechi 547000,Guangxi,China)
关键词:
孟鲁司特钠布地奈德儿童支气管哮喘变应性鼻炎
Keywords:
Montelukast sodiumBudesonideChildrenBronchial asthmaAllergic rhinitis
分类号:
R562.2
DOI:
10.3969/j.issn.1006-1959.2019.20.044
文献标志码:
A
摘要:
目的 观察布地奈德联合孟鲁司特钠对儿童支气管哮喘合并变应性鼻炎的临床疗效及对炎性反应指标的影响,为进一步提高其治疗效果提供参考。方法 选择2018年1月~12月我院收治的106例支气管哮喘合并变应性鼻炎患儿,随机分为对照组和观察组,各53例。对照组给予布地奈德治疗,观察组在对照组的基础上联合孟鲁司特钠治疗,比较两组治疗前后哮喘症状评分、过敏性鼻炎症状评分、血清白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)水平。结果 对照组哮喘症状评分为(6.59±2.21)分,高于观察组的(4.92±1.95)分,差异有统计学意义(P<0.05);对照组过敏性鼻炎症状评分为(4.20±1.37)分,高于观察组的(3.52±1.26)分,差异有统计学意义(P<0.05);对照组血清IL-6水平为(109.48±26.37)ng/L,高于观察组的(93.79±23.62)ng/L,差异有统计学意义(P<0.05);对照组血清TNF-α水平为(351.39±46.37)ng/L,高于观察组的(313.50±37.15) ng/L,差异有统计学意义(P<0.05)。结论 孟鲁司特钠联合布地奈德可有效改善支气管哮喘合并变应性鼻炎儿童的临床症状及炎性反应指标,具有良好临床效果。
Abstract:
Objective To observe the clinical efficacy of budesonide combined with montelukast sodium in children with bronchial asthma complicated with allergic rhinitis and its influence on inflammatory response index, and provide reference for further improving its therapeutic effect. Methods 106 children with bronchial asthma complicated with allergic rhinitis were enrolled in our hospital from January to December 2018. They were randomly divided into control group and observation group, with 53 cases in each group. The control group was treated with budesonide. The observation group was treated with montelukast sodium on the basis of the control group. The asthma symptom score, allergic rhinitis symptom score, serum interleukin-6 (IL-6) were compared before and after treatment. And tumor necrosis factor-α (TNF-α) levels. Results The asthma symptom score of the control group was (6.59±2.21), which was higher than that of the observation group (4.92±1.95),the difference was statistically significant (P<0.05). The score of allergic rhinitis symptoms in the control group was (4.20±1.37). Compared with the observation group (3.52±1.26), the difference was statistically significant (P<0.05); the serum IL-6 level of the control group was (109.48±26.37) ng/L, which was higher than that of the observation group (93.79±23.62)ng/L, the difference was statistically significant (P<0.05); the serum TNF-α level in the control group was (351.39±46.37) ng/L, which was higher than that of the observation group (313.50±37.15) ng/L,the difference was statistically significant (P<0.05). Conclusion Montelukast sodium combined with budesonide can effectively improve the clinical symptoms and inflammatory response of children with bronchial asthma complicated with allergic rhinitis, and has good clinical results.

参考文献/References:

[1]王雯,刘继贤.儿童支气管哮喘影响因素分析[J].中国实用儿科杂志,2015,30(6):441-445. [2]刘争,王男.儿童变应性鼻炎的诊断与治疗[J].临床耳鼻咽喉头颈外科杂志,2015,29(3):199-201. [3]Chai R,Liu B,Qi F.The significance of the levels of IL-4, IL-31 and TLSP in patients with asthma and/or rhinitis[J].Immunotherapy,2017,9(4):331-337. [4]Morina N,Haliti A,Iljazi A,et al.Comparison of Effect of Leukotriene Biosynthesis Blockers and Inhibitors of Phosphodiesterase Enzyme in Patients with Bronchial Hyperreactivity[J].Open Access Macedonian Journal of Medical Sciences,2018,6(5):777-781. [5]栗绪娥,郭艳,郝素革,等.孟鲁司特联合延伸护理在小儿支气管哮喘患儿中的应用分析[J].海南医学院学报,2017,23(1):139-141. [6]仲云龙.布地奈德联合孟鲁司特钠治疗小儿支气管哮喘合并过敏性鼻炎的效果探讨[J].当代医药论丛,2017,15(19):190-191. [7]Rahman MA,Chakraborty R,Ferdousi KR,et al.New Therapeutic Approach to Treat Allergic Rhinitis & Bronchial Asthma, Considering These Two as One United Airway Disease[J].Mymensingh Medical Journal Mmj,2017,26(1):216-221. [8]Lin J,Lin C,Yen H,et al.Increased Risk of Tics in Children Infected with Enterovirus: A Nationwide Population-based Study[J].Journal of Developmental & Behavioral Pediatrics Jdbp,2017,38(4):276-282. [9]刘英丽,徐梅佳,吕伟,等.孟鲁司特钠联合布地奈德对哮喘患儿肺功能、炎症因子及免疫球蛋白水平的影响[J].海南医学院学报,2017,23(24):3404-3407. [10]姜梁,胡晓艳.儿童变应性鼻炎严重程度与外周血嗜酸细胞阳离子蛋白、内皮素和肿瘤坏死因子-α的水平变化的关系[J].中国妇幼保健,2013,28(1):147-149. [11]Li HT,Chen ZG,Lin YS,et al.CpG-ODNs and Budesonide Act Synergistically to Improve Allergic Responses in Combined Allergic Rhinitis and Asthma Syndrome Induced by Chronic Exposure to Ovalbumin by Modulating the TSLP-DC-OX40L Axis[J].Inflammation,2018,41(4):1304-1320. [12]Hui C,Hongfei L,Yang W,et al.Comparison of the efficacy and mechanisms of intranasal budesonide, montelukast, and their combination in treatment of patients with seasonal allergic rhinitis[J].International Forum of Allergy & Rhinology,2018,8(11):1242-1252. [13]胡宇敏.孟鲁司特联合布地奈德用于儿童哮喘及过敏性鼻炎效果分析[J].中国卫生标准管理,2018,9(11):61-62.

相似文献/References:

[1]李波.孟鲁司特钠联合酮替芬治疗小儿支气管炎的临床效果分析[J].医学信息,2018,(02):130.[doi:10.3969/j.issn.1006-1959.2018.02.048]
 LI Bo.Clinical Analysis of Montelukast Sodium Combined With Ketotifen in the Treatment of Bronchitis in Children[J].Medical Information,2018,(20):130.[doi:10.3969/j.issn.1006-1959.2018.02.048]
[2]马建娟.布地奈德联合异丙托溴铵雾化治疗COPD 急性加重期的效果评价[J].医学信息,2018,(07):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]
 MA Jian-juan.Efficacy Evaluation of Budesonide Combined with Ipratropium Bromide in Treatment of Acute Exacerbation of COPD[J].Medical Information,2018,(20):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]
[3]尹静华.孟鲁司特钠治疗小儿哮喘的临床有效性分析[J].医学信息,2018,(09):138.[doi:10.3969/j.issn.1006-1959.2018.09.043]
 YIN Jing-hua.Clinical Efficacy of Montelukast Sodium in Children with Asthma[J].Medical Information,2018,(20):138.[doi:10.3969/j.issn.1006-1959.2018.09.043]
[4]罗玉霞.舒适护理在布地奈德联合氨溴索雾化吸入治疗 慢阻肺急性发作患者的效果分析[J].医学信息,2018,(12):179.[doi:10.3969/j.issn.1006-1959.2018.12.058]
 LUO Yu-xia.Analysis of the Effect of Comfortable Nursing in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients with Aerosolized Inhalation of Budesonide and Ambroxol[J].Medical Information,2018,(20):179.[doi:10.3969/j.issn.1006-1959.2018.12.058]
[5]曾穗茹,王蓉梅.孟鲁司特联合布地奈德雾化吸入用于肺炎支原体感染后慢性咳嗽患儿的效果观察[J].医学信息,2018,(19):137.[doi:10.3969/j.issn.1006-1959.2018.19.041]
 ZENG Sui-ru,WANG Rong-mei.Efficacy of Montelukast Combined with Budesonide Aerosol Inhalation in Children with Chronic Cough after Mycoplasma Pneumoniae Infection[J].Medical Information,2018,(20):137.[doi:10.3969/j.issn.1006-1959.2018.19.041]
[6]邱亚双.辛夷鼻炎丸联合布地奈德治疗变应性鼻炎的临床观察[J].医学信息,2019,(03):158.[doi:10.3969/j.issn.1006-1959.2019.03.052]
 QIU Ya-shuang.Clinical Observation of Xinyi Biyan Wan Combined with Budesonide in Treating Allergic Rhinitis[J].Medical Information,2019,(20):158.[doi:10.3969/j.issn.1006-1959.2019.03.052]
[7]周 佳,柴明思.布地奈德、异丙托溴铵气雾剂联合雾化吸入治疗对肺气肿患者肺功能及血液相关指标的影响[J].医学信息,2019,(09):151.[doi:10.3969/j.issn.1006-1959.2019.09.050]
 ZHOU Jia,CHAI Ming-si.Effects of Budesonide and Ipratropium Bromide Aerosol Combined with Nebulized Inhalation on Pulmonary Function and Blood Related Indexes in Patients with Emphysema[J].Medical Information,2019,(20):151.[doi:10.3969/j.issn.1006-1959.2019.09.050]
[8]刘江海.异丙托溴铵雾化吸入治疗慢阻肺急性加重期的临床疗效[J].医学信息,2019,(20):150.[doi:10.3969/j.issn.1006-1959.2019.20.047]
 LIU Jiang-hai.Clinical Efficacy of Ipratropium Bromide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Medical Information,2019,(20):150.[doi:10.3969/j.issn.1006-1959.2019.20.047]
[9]张明荣.孟鲁司特钠联合布地奈德治疗小儿哮喘的临床疗效分析[J].医学信息,2018,(13):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
 ZHANG Ming-rong.Clinical Analysis of Montelukast Sodium Combined with Budesonide in the Treatment of Childhood Asthma[J].Medical Information,2018,(20):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
[10]甘 瀛.孟鲁司特钠联合布地奈德治疗小儿咳嗽变异性哮喘的疗效[J].医学信息,2019,(12):150.[doi:10.3969/j.issn.1006-1959.2019.12.049]
 GAN Ying.Efficacy of Montelukast Sodium Combined with Budesonide in the Treatment of Cough Variant Asthma in Children[J].Medical Information,2019,(20):150.[doi:10.3969/j.issn.1006-1959.2019.12.049]

更新日期/Last Update: 2019-10-15